Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PANTOPRAZOLE Cause Respiratory failure? 280 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 280 reports of Respiratory failure have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.4% of all adverse event reports for PANTOPRAZOLE.

280
Reports of Respiratory failure with PANTOPRAZOLE
0.4%
of all PANTOPRAZOLE reports
104
Deaths
197
Hospitalizations

How Dangerous Is Respiratory failure From PANTOPRAZOLE?

Of the 280 reports, 104 (37.1%) resulted in death, 197 (70.4%) required hospitalization, and 56 (20.0%) were considered life-threatening.

Is Respiratory failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 280 reports have been filed with the FAERS database.

What Other Side Effects Does PANTOPRAZOLE Cause?

Chronic kidney disease (28,127) Acute kidney injury (15,961) Renal failure (11,543) End stage renal disease (8,523) Renal injury (7,070) Drug ineffective (5,487) Off label use (4,279) Pain (4,057) Dyspnoea (4,052) Fatigue (3,797)

What Other Drugs Cause Respiratory failure?

PREDNISONE (2,299) CYCLOPHOSPHAMIDE (2,096) RITUXIMAB (1,838) TACROLIMUS (1,758) METHOTREXATE (1,685) DEXAMETHASONE (1,603) MYCOPHENOLATE MOFETIL (1,469) METHYLPREDNISOLONE (1,442) PREDNISOLONE (1,346) VINCRISTINE (1,120)

Which PANTOPRAZOLE Alternatives Have Lower Respiratory failure Risk?

PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS PANTOPRAZOLE vs PANTOTHENIC ACID PANTOPRAZOLE vs PAPAVERINE PANTOPRAZOLE vs PARACETAMOL PANTOPRAZOLE vs PARATHYROID HORMONE

Related Pages

PANTOPRAZOLE Full Profile All Respiratory failure Reports All Drugs Causing Respiratory failure PANTOPRAZOLE Demographics